ASCA101 IV
/ MetaFines
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 13, 2024
Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: MetaFines | Recruiting ➔ Completed | Trial completion date: Oct 2023 ➔ Feb 2024 | Trial primary completion date: Jul 2023 ➔ Feb 2024
Metastases • Trial completion • Trial completion date • Trial primary completion date • Hepatocellular Cancer • Oncology • Solid Tumor
September 21, 2022
Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: MetaFines
New P1 trial • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1